174 related articles for article (PubMed ID: 21882191)
41. Role of ion transporters in the bile acid-induced esophageal injury.
Laczkó D; Rosztóczy A; Birkás K; Katona M; Rakonczay Z; Tiszlavicz L; Róka R; Wittmann T; Hegyi P; Venglovecz V
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G16-31. PubMed ID: 27198194
[TBL] [Abstract][Full Text] [Related]
42. Transitional basal cells at the squamous-columnar junction generate Barrett's oesophagus.
Jiang M; Li H; Zhang Y; Yang Y; Lu R; Liu K; Lin S; Lan X; Wang H; Wu H; Zhu J; Zhou Z; Xu J; Lee DK; Zhang L; Lee YC; Yuan J; Abrams JA; Wang TC; Sepulveda AR; Wu Q; Chen H; Sun X; She J; Chen X; Que J
Nature; 2017 Oct; 550(7677):529-533. PubMed ID: 29019984
[TBL] [Abstract][Full Text] [Related]
43. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
[TBL] [Abstract][Full Text] [Related]
44. Barrett's metaplasia as a paradigm for understanding the development of cancer.
Burke ZD; Tosh D
Curr Opin Genet Dev; 2012 Oct; 22(5):494-9. PubMed ID: 22981230
[TBL] [Abstract][Full Text] [Related]
45. Prevalence and topography of intestinal metaplasia in columnar lined esophagus.
Jego M; Volant A; Faycal J; Doucet L; Andlauer E; Delalande AH; Cholet F; Nousbaum JB; Gouérou H; Robaszkiewicz M
Gastroenterol Clin Biol; 2007; 31(6-7):601-6. PubMed ID: 17646787
[TBL] [Abstract][Full Text] [Related]
46. Non-goblet cell population of Barrett's esophagus: an immunohistochemical demonstration of intestinal differentiation.
Chaves P; Cardoso P; de Almeida JC; Pereira AD; Leitao CN; Soares J
Hum Pathol; 1999 Nov; 30(11):1291-5. PubMed ID: 10571507
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines.
Feagins LA; Zhang HY; Zhang X; Hormi-Carver K; Thomas T; Terada LS; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G411-7. PubMed ID: 18063706
[TBL] [Abstract][Full Text] [Related]
48. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
El-Zimaity HM; Graham DY
Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671
[TBL] [Abstract][Full Text] [Related]
49. In-depth characterization of the Wnt-signaling/β-catenin pathway in an in vitro model of Barrett's sequence.
Götzel K; Chemnitzer O; Maurer L; Dietrich A; Eichfeld U; Lyros O; Moulla Y; Niebisch S; Mehdorn M; Jansen-Winkeln B; Vieth M; Hoffmeister A; Gockel I; Thieme R
BMC Gastroenterol; 2019 Mar; 19(1):38. PubMed ID: 30841855
[TBL] [Abstract][Full Text] [Related]
50. Math1/Atoh1 contributes to intestinalization of esophageal keratinocytes by inducing the expression of Muc2 and Keratin-20.
Kong J; Crissey MA; Sepulveda AR; Lynch JP
Dig Dis Sci; 2012 Apr; 57(4):845-57. PubMed ID: 22147253
[TBL] [Abstract][Full Text] [Related]
51. Epidemiology of Barrett's Esophagus and Esophageal Carcinoma.
Fabian T; Leung A
Surg Clin North Am; 2021 Jun; 101(3):381-389. PubMed ID: 34048759
[TBL] [Abstract][Full Text] [Related]
52. In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks.
Zhang HY; Hormi-Carver K; Zhang X; Spechler SJ; Souza RF
Cancer Res; 2009 Dec; 69(23):9083-9. PubMed ID: 19920191
[TBL] [Abstract][Full Text] [Related]
53. Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagus.
Going JJ; Fletcher-Monaghan AJ; Neilson L; Wisman BA; van der Zee A; Stuart RC; Keith WN
Neoplasia; 2004; 6(1):85-92. PubMed ID: 15068673
[TBL] [Abstract][Full Text] [Related]
54. Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T).
Jaiswal KR; Morales CP; Feagins LA; Gandia KG; Zhang X; Zhang HY; Hormi-Carver K; Shen Y; Elder F; Ramirez RD; Sarosi GA; Spechler SJ; Souza RF
Dis Esophagus; 2007; 20(3):256-64. PubMed ID: 17509124
[TBL] [Abstract][Full Text] [Related]
55. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
Buttar NS; Wang KK; Anderson MA; Dierkhising RA; Pacifico RJ; Krishnadath KK; Lutzke LS
J Natl Cancer Inst; 2002 Mar; 94(6):422-9. PubMed ID: 11904314
[TBL] [Abstract][Full Text] [Related]
56. A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus.
Goldman A; Shahidullah M; Goldman D; Khailova L; Watts G; Delamere N; Dvorak K
Gut; 2010 Dec; 59(12):1606-16. PubMed ID: 20876775
[TBL] [Abstract][Full Text] [Related]
57. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.
Feith M; Stein HJ; Mueller J; Siewert JR
Dis Esophagus; 2004; 17(4):322-7. PubMed ID: 15569371
[TBL] [Abstract][Full Text] [Related]
58. Novel findings in the pathogenesis of esophageal columnar metaplasia or Barrett's esophagus.
Krishnadath KK
Curr Opin Gastroenterol; 2007 Jul; 23(4):440-5. PubMed ID: 17545783
[TBL] [Abstract][Full Text] [Related]
59. Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis.
Goldman A; Chen HD; Roesly HB; Hill KA; Tome ME; Dvorak B; Bernstein H; Dvorak K
Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G292-302. PubMed ID: 21127259
[TBL] [Abstract][Full Text] [Related]
60. Histological and anatomic changes in Barrett's esophagus after antireflux surgery.
Low DE; Levine DS; Dail DH; Kozarek RA
Am J Gastroenterol; 1999 Jan; 94(1):80-5. PubMed ID: 9934735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
